The short version
What teams need to understand
- Pharmacovigilance systems must operate a structured regulatory intelligence framework.
- Regulatory intelligence must continuously identify and monitor global and local regulatory changes.
- Identified regulatory changes must be assessed for impact on the PV system.
- Impact assessments must drive decisions and defined actions to ensure compliance.
- Regulatory changes must be implemented, tracked, and governed through controlled processes.
- Inspection-ready evidence must demonstrate a complete and continuous regulatory intelligence lifecycle.
Regulatory expectation
What regulators expect
Each expectation should be supported by controlled documentation, traceable records, clear ownership, and evidence that the process works in practice.
- Regulatory changes must be continuously monitored.
- All relevant regulatory updates must be assessed for impact.
- Regulatory intelligence must drive defined actions.
- Implementation must be tracked and completed.
- The PV system must remain compliant with current regulations.
Why it matters
What this means in practice
Inspectors assess whether pharmacovigilance systems operate a structured regulatory intelligence framework. They review how regulatory changes are identified, assessed, implemented, tracked, and governed to ensure continuous compliance across global and local requirements.
Questions this page answers
Inspection evidence
Evidence teams should be able to show
Regulatory Intelligence SOP
- Defined regulatory intelligence lifecycle
- Roles and responsibilities for monitoring and assessment
- Processes for identifying and evaluating regulatory changes
- Integration with PV quality system
Regulatory Intelligence Tracker
- Central log of regulatory changes
- Tracking of identification, assessment, and action status
- Assignment of owners and deadlines
- Status updates from identification to completion
Impact Assessment Documentation
- Structured evaluation of regulatory changes
- Gap analysis against current PV processes
- Risk and impact classification
- Defined action plans and implementation decisions
Implementation and Action Records
- Defined actions to address regulatory changes
- Evidence of SOP updates and system changes
- Training triggered by regulatory updates
- Completion of required compliance actions
Governance and Oversight Evidence
- Monthly regulatory intelligence meetings
- Documented decisions and action tracking
- Cross-functional participation (PV, RA, QA)
- Management oversight of regulatory changes
Continuous Monitoring and Sources
- Monitoring of global regulatory authorities
- Local affiliate regulatory updates
- Defined monitoring frequency and responsibilities
- Evidence of routine source review
Regulatory Basis (Primary Sources)
- GVP Module I - requirement for PV system compliance and oversight
- GVP Module VI - requirements for safety data management aligned with regulations
- ICH E2E - pharmacovigilance planning and anticipation of regulatory requirements
- MHRA GPvP guidance - expectations for monitoring regulatory changes
- FDA pharmacovigilance guidance - requirement to remain compliant with evolving regulations
Typical Inspection Questions (What Inspectors Ask)
- How do you stay up to date with regulatory changes?
- Show me your regulatory intelligence tracker.
- How do you assess the impact of new regulations?
- How do you ensure changes are implemented?
- How is regulatory intelligence governed in your organisation?
Common failure patterns
What good looks like
- A structured and documented regulatory intelligence framework.
- Continuous monitoring of global and local regulatory sources.
- Defined impact assessment and decision-making process.
- Tracked implementation of regulatory changes.
- Governance ensuring regulatory compliance is maintained.
How teams operationalise it
- Define a regulatory intelligence process within PV SOPs.
- Monitor regulatory sources continuously.
- Log regulatory changes in a central tracker.
- Perform structured impact assessments.
- Define and implement required actions.
- Review regulatory intelligence through governance processes.
From expectation to working control
Find the documentation that supports this work
Review the related toolkit to understand its purpose, included files, and how it supports this regulatory expectation.
Frequently asked questions
What is regulatory intelligence in pharmacovigilance?
Regulatory intelligence is the process of monitoring, assessing, and implementing regulatory changes to ensure ongoing compliance with pharmacovigilance requirements.
How do companies stay compliant with changing PV regulations?
Companies use structured regulatory intelligence processes to monitor updates, assess impact, and implement required changes within their PV systems.
Do inspectors review regulatory intelligence processes?
Yes. Inspectors assess whether companies have a structured and effective process for identifying and implementing regulatory changes.
What is a regulatory intelligence tracker?
A regulatory intelligence tracker is a central log used to record regulatory changes, track their assessment, and monitor implementation actions.
How are regulatory changes implemented in pharmacovigilance?
Changes are implemented through defined actions such as SOP updates, system changes, training, and governance oversight.
Why is regulatory intelligence important?
Regulatory intelligence ensures that pharmacovigilance systems remain compliant with evolving global and local requirements.
Source boundary
Regulatory sources
These primary sources inform this structured interpretation. Always confirm current requirements against the original source and the requirements applicable to your organisation, product, and jurisdiction.
European Medicines Agency (EMA)
Guideline on good pharmacovigilance practices (GVP) - Module I
View sourceGuideline on good pharmacovigilance practices (GVP) - Module VI
View source
FDA
FDA Postmarketing Safety Reporting
View source
ICH
ICH E2E Pharmacovigilance Planning
View source
MHRA
Good Pharmacovigilance Practice (GPvP)
View source